Their WEED stock forecasts range from C$2.50 to C$22.00. On average, they anticipate Canopy Growth's stock price to reach C$8.83 in the next twelve months. This suggests a possible upside of 90.4% from the stock's current price.
Full Answer
What's the price targets for Canopy Growth's Stock?
Their forecasts range from C$25.00 to C$75.00. On average, they expect Canopy Growth's stock price to reach C$49.90 in the next twelve months. This suggests a possible upside of 107.4% from the stock's current price. View Analyst Price Targets for Canopy Growth.
When is Canopy Growth going to release its quarterly earnings?
Canopy Growth is scheduled to release its next quarterly earnings announcement on Wednesday, February 9th 2022. View our earnings forecast for Canopy Growth. What price target have analysts set for WEED?
Is Canopy Growth the best cannabis stock to own?
Canopy Growth ( NASDAQ: CGC ), once known as the top cannabis stock to own, has seen its stock drop to levels that it was trading at before it ever achieved the hype it did in 2018.
See more
What is the price Target for Canopy Growth?
The 15 analysts offering 12-month price forecasts for Canopy Growth Corp have a median target of 4.74, with a high estimate of 6.89 and a low estimate of 3.00. The median estimate represents a -0.83% decrease from the last price of 4.78.
Is Canopy Growth a Buy Sell or Hold?
Canopy Growth has received a consensus rating of Hold. The company's average rating score is 1.59, and is based on 2 buy ratings, 6 hold ratings, and 9 sell ratings.
Should I hold Canopy Growth?
Canopy Growth Corporation - Hold Valuation metrics show that Canopy Growth Corporation may be overvalued. Its Value Score of F indicates it would be a bad pick for value investors. The financial health and growth prospects of CGC, demonstrate its potential to underperform the market.
Will canopy stock go up?
The company does not currently pay any dividends to shareholders and is therefore not a yield stock. However, current analysis suggests that the share price can still rise, as shown by the share's performance in March 2022 with a gain of 19.80%.
Will Canopy Growth ever pay dividends?
Does Canopy Growth Corporation pay a dividend? Canopy Growth Corporation does not currently pay a dividend and has no current plans to introduce one in the future.
Who owns Canopy Growth?
Constellation BrandsIn August 2018, Constellation Brands – an American beer, wine and spirits producer with global markets – announced its investment of an additional C$5 billion (US$3.8 billion) in Canopy Growth, giving it 38% ownership of the company, up from the previous 10%.
What is the future for Canopy Growth?
Canopy Growth Corp. CGC had a small drop in revenue from its fiscal year 2021 to 2022, at a time when cannabis sales were solid around the world. However, moving into 2023, projections show revenue hitting $471.7 million — a 10.7% increase from 2022.
Why is CGC stock dropping?
Canopy Growth reported a 36% drop in revenue from Canadian recreational cannabis sales compared with the same quarter a year ago. Canopy Growth stock is plummeting after the marijuana company delivered financial results that fell short of expectations.
Should I buy Cgsi stock?
If you are looking for stocks with good return, CGS International Inc can be a profitable investment option. CGS International Inc quote is equal to 0.120 USD at 2022-07-29. Based on our forecasts, a long-term increase is expected, the "CGSI" stock price prognosis for 2027-07-26 is 7.469 USD.
What's happening to Canopy Growth?
Retirement of Approximately $263 Million of Debt Strengthens Canopy Growth's Balance Sheet and Preserves Cash to Support Future Growth SMITHS FALLS, ONTARIO (July 18, 2022) – Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC) announced today that it has closed (the “Final Closing”) ...
Why is Canopy Growth stock dropping?
Canopy Growth reported a 36% drop in revenue from Canadian recreational cannabis sales compared with the same quarter a year ago. Canopy Growth stock is plummeting after the marijuana company delivered financial results that fell short of expectations.
Should I buy or sell Canopy Growth stock right now?
15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Canopy Growth in the last twelve months. There are curr...
What is Canopy Growth's stock price forecast for 2022?
15 Wall Street research analysts have issued 12-month price objectives for Canopy Growth's shares. Their CGC stock forecasts range from $3.50 to $2...
How has Canopy Growth's stock price performed in 2022?
Canopy Growth's stock was trading at $8.73 at the beginning of 2022. Since then, CGC shares have decreased by 58.2% and is now trading at $3.65. V...
When is Canopy Growth's next earnings date?
Canopy Growth is scheduled to release its next quarterly earnings announcement on Friday, August 5th 2022. View our earnings forecast for Canopy G...
How were Canopy Growth's earnings last quarter?
Canopy Growth Co. (NASDAQ:CGC) announced its quarterly earnings results on Friday, May, 27th. The company reported ($1.46) earnings per share (EPS)...
Who are Canopy Growth's key executives?
Canopy Growth's management team includes the following people: Mr. David Eric Klein , CEO & Director (Age 58, Pay $2.79M) Mr. Julious C. Grant J...
Who are some of Canopy Growth's key competitors?
Some companies that are related to Canopy Growth include Tilray (TLRY) , USANA Health Sciences (USNA) , Cronos Group (CRON) , Cresco Labs (CRLB...
What is Canopy Growth's stock symbol?
Canopy Growth trades on the NASDAQ under the ticker symbol "CGC."
Who are Canopy Growth's major shareholders?
Canopy Growth's stock is owned by many different retail and institutional investors. Top institutional investors include Vanguard Group Inc. (2.00%...
Canopy Stock Forecast 2018
January was, by all accounts, a rough month for the marijuana industry. Companies both big and small suffered as stock prices near universally plum...
How Canada Marijuana Legalization Could Boost The Stock
The marijuana stock story of the year is naturally going to be Canadian marijuana legalization.When the laws eventually roll through Canada’s parli...
Canopy vs Aurora: The Better Investment
While I’m big on Canopy stock, there are obviously competitors. Take Aurora Cannabis Inc (OTCMKTS:ACBFF, TSE:ACB), for instance. Both Aurora and Ca...
Should You Consider A Canopy Investment?
There are a lot of reasons to be happy about Canopy’s most recent moves on the market.The Canopy-Australia partnership with Auscann Group Holdings...
Canopy Stock Forecast 2018
January was, by all accounts, a rough month for the marijuana industry. Companies both big and small suffered as stock prices near universally plummeted in a pretty massive correction. Many of the biggest weed companies fell by over 20% in the month.
How Canada Marijuana Legalization Could Boost the Stock
The marijuana stock story of the year is naturally going to be Canadian marijuana legalization.
Canopy vs Aurora: The Better Investment
While I’m big on Canopy stock, there are obviously competitors. Take Aurora Cannabis Inc (OTCMKTS:ACBFF, TSE:ACB), for instance. Both Aurora and Canopy are strong companies, both are growing more powerful in the still-young marijuana market, and both are susceptible to a major potential political development in 2018: a U.S. crackdown on marijuana.
Should You Consider a Canopy Investment?
There are a lot of reasons to be happy about Canopy’s most recent moves on the market.
Analyst Take
Between deals being made in Australia—including one with the Victorian State Government—and its otherwise solid market position, I believe that the January blues will quickly fade into memory as Canopy stock price forecast climb back to $30.00.
The future is usually hazy. But for Canopy Growth, the skies could be mainly blue
Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights
What will make the difference
The future for Canopy Growth could look very different depending on several factors. Perhaps the most important factor of all is just how big the global marijuana market will become over the next five years.
A wide variety of potential outcomes
If you're a pessimist, you could probably envision demand increasing more slowly than supply over the next five years. That could create a scenario where Canopy Growth must compete primarily on price. Such a commoditized market is exactly what the company doesn't want to see.
Most likely scenario
It's impossible to know for sure what the future holds. My best guess is that Canopy Growth won't exist five years from now -- at least not as a stand-alone entity.
Where is canopy growth traded?
Canopy Growth trades on the Toronto Stock Exchange (TSX) under the ticker symbol "WEED."
What is canopy growth?
Canopy Growth Corporation, together with its subsidiaries, engages in growing, possession, and sale of medical cannabis in Canada. Its products include dried flowers, oils and concentrates, softgel capsules, and hemps. The company offers its products under the Tweed, Black Label, Spectrum Cannabis, DNA Genetics, Leafs By Snoop, CraftGrow, and Foria brand names. It also offers its products through Tweed Main Street, a single online platform that enables registered patients to purchase medicinal cannabis from various producers across various brands. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada to investigate the efficacy of cannabinoids for the treatment of post-concussion neurological diseases in former NHL players; and partnership with Parent Action on Drugs. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
What is the P/E ratio of canopy growth?
The P/E ratio of Canopy Growth is -4.32, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Does canopy growth pay dividends?
Canopy Growth does not currently pay a dividend.
Analyst price target for CGC
Based on 6 analyst s offering 12 month price targets for Canopy Growth Corp.
CGC earnings per share forecast
What is CGC 's earnings per share in the next 3 years based on estimates from 8 analyst s?
CGC revenue forecast
What is CGC 's revenue in the next 3 years based on estimates from 5 analyst s?
CGC revenue growth forecast
How is CGC forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Stock Price Forecast
The 15 analysts offering 12-month price forecasts for Canopy Growth Corp have a median target of 8.65, with a high estimate of 14.00 and a low estimate of 5.52. The median estimate represents a +21.08% increase from the last price of 7.14.
Analyst Recommendations
The current consensus among 20 polled investment analysts is to Hold stock in Canopy Growth Corp. This rating has held steady since February, when it was unchanged from a Hold rating. Move your mouse over past months for detail
What is canopy growth?
The Canopy Growth Corporation, together with its subsidiaries, manufactures, distributes and markets cannabis for recreational and medical purposes, primarily in Canada, the United States, Germany and the United Kingdom. It operates in two segments: cannabis, hemp and other consumer products; and hinged rivers. The company’s products include dried cannabis flowers, oils and concentrates, and soft capsules. It offers its products under Tweed, Quatreau, Deep Space, Healing Spectrum, First and Free, Taiwan Dollar, It Works, BioSteel, CraftGrow DNA Genetics, Tokyo Smoke, Changed, Delicious Parcels, Van der Pop, and Beans and Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and the NHL Alumni Association to study the efficacy of CBD-based therapy in alleviating persistent post-exposure symptoms. As of February 14, 2020, she operated 28 cannabis retail stores called Tweed or Tokyo Smoke. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smits Falls, Canada.
What does the final quote on a canopy mean?
The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Canopy Growth shares. This happens once a day.
How to calculate market capitalization?
It is calculated by the formula multiplying the number of shares in the company outstanding by the market price of one share.
What is dividend yield?
Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.
